PRTN3 and rheumatoid arthritis: All these results are in line with previous findings by Melis et al. [37], and confirm recent work reporting that ACPA positive RA patients had significantly higher levels of IL-17 in SF compared with ACPA negative patients [12], suggesting that the IL-17 pathway may play a greater role in the pathogenesis of ACPA positive RA.